163 related articles for article (PubMed ID: 8380324)
1. The pathogenesis of wild type and drug resistant mutant strains of bovine herpesvirus-1 (BHV-1) in the natural host.
Gilliam SE; Thackray AM; Brown GA; Field HJ
Arch Virol; 1993; 128(1-2):43-54. PubMed ID: 8380324
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves.
Kit S; Qavi H; Gaines JD; Billingsley P; McConnell S
Arch Virol; 1985; 86(1-2):63-83. PubMed ID: 2994602
[TBL] [Abstract][Full Text] [Related]
3. Comparative pathogenesis of acute and latent infections of calves with bovine herpesvirus types 1 and 5.
Meyer G; Lemaire M; Ros C; Belak K; Gabriel A; Cassart D; Coignoul F; Belak S; Thiry E
Arch Virol; 2001; 146(4):633-52. PubMed ID: 11402854
[TBL] [Abstract][Full Text] [Related]
4. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
5. The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle.
Gilliam SE; Field HJ
Antiviral Res; 1993 Jan; 20(1):21-32. PubMed ID: 8384432
[TBL] [Abstract][Full Text] [Related]
6. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant.
Whetstone CA; Miller JM; Seal BS; Bello LJ; Lawrence WC
Arch Virol; 1992; 122(1-2):207-14. PubMed ID: 1309641
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves.
Inman M; Lovato L; Doster A; Jones C
J Virol; 2002 Jul; 76(13):6771-9. PubMed ID: 12050390
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
[TBL] [Abstract][Full Text] [Related]
9. A bovine herpesvirus type 1 mutant virus specifying a carboxyl-terminal truncation of glycoprotein E is defective in anterograde neuronal transport in rabbits and calves.
Liu ZF; Brum MC; Doster A; Jones C; Chowdhury SI
J Virol; 2008 Aug; 82(15):7432-42. PubMed ID: 18480434
[TBL] [Abstract][Full Text] [Related]
10. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
Wei H; He J; Paulsen DB; Chowdhury SI
Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
[TBL] [Abstract][Full Text] [Related]
11. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
12. Experimental infection of neonatal calves with neurovirulent bovine herpesvirus type 1.3.
Belknap EB; Collins JK; Ayers VK; Schultheiss PC
Vet Pathol; 1994 May; 31(3):358-65. PubMed ID: 8053131
[TBL] [Abstract][Full Text] [Related]
13. An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization.
Liang X; Babiuk LA; Zamb TJ
Virology; 1992 Aug; 189(2):629-39. PubMed ID: 1322592
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
[TBL] [Abstract][Full Text] [Related]
15. Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteroids in an intranasal rabbit model.
Brown GA; Field HJ
Arch Virol; 1990; 112(1-2):81-101. PubMed ID: 2164377
[TBL] [Abstract][Full Text] [Related]
16. Association between route of inoculation with infectious bovine rhinotracheitis virus and site of recrudescence after dexamethasone treatment.
Rossi CR; Kiesel GK; Rumph PF
Am J Vet Res; 1982 Aug; 43(8):1440-2. PubMed ID: 6285780
[TBL] [Abstract][Full Text] [Related]
17. Bovine herpesvirus-1 and parainfluenza-3 virus interactions: clinical and immunological response in calves.
Ghram A; Reddy PG; Morrill JL; Blecha F; Minocha HC
Can J Vet Res; 1989 Jan; 53(1):62-7. PubMed ID: 2536581
[TBL] [Abstract][Full Text] [Related]
18. Changes in the bovine herpesvirus 1 genome during acute infection, after reactivation from latency, and after superinfection in the host animal.
Whetstone CA; Miller JM; Bortner DM; Van der Maaten MJ
Arch Virol; 1989; 106(3-4):261-79. PubMed ID: 2549919
[TBL] [Abstract][Full Text] [Related]
19. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
20. Attempts to reactivate bovid herpesvirus-2 in experimentally infected calves.
Castrucci G; Frigeri F; Cilli V; Tesei B; Arush AM; Pedini B; Ranucci S; Rampichini L
Am J Vet Res; 1980 Nov; 41(11):1890-3. PubMed ID: 6259974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
